Nuclear mitotic apparatus protein 1 (NuMA1) was employed as a biomarker, as it demonstrates overexpression in urothelial cancers and the nanoplatforms were able to detect this biomarker on the surface of bladder cancer cells. The gene discussed is NUMA1; the disease is urinary bladder carcinoma.